


Arrakis Therapeutics Email Formats
Pharmaceutical Manufacturing • Waltham, Massachusetts, United States • 51-100 Employees
Arrakis Therapeutics Email Formats
Arrakis Therapeutics uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@arrakistx.com), used 88.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@arrakistx.com | 88.4% |
{first name}{last name} | johndoe@arrakistx.com | 7% |
{last name}{last name} | doedoe@arrakistx.com | 2.3% |
{last name} | doe@arrakistx.com | 2.3% |
Key Contacts at Arrakis Therapeutics
Jennifer Petter
Founder & Chief Scientific Officer
Michael Gilman
Chief Executive Officer
Gary Vogel
Associate Director, Hr
Nick Marsh
Senior Director, Head Of Molecular Pharmacology
Aaron Frank
Director And Head Of Computational Chemistry
Luis Soares
Associate Director - Head Of Computational Biology
Elena Menichelli
Director, Head Of Structural Biology
Emily Garcia Sega
Associate Director
Alexandra Gehring
Associate Director, Rna Biology
Sarah Mahoney
Director, Discovery Biology
Company overview
| Headquarters | 828 Winter Street, Waltham, MA 02451, US |
| Phone number | +18574884488 |
| Website | |
| NAICS | 3254 |
| SIC | 873 |
| Founded | 2015 |
| Employees | 51-100 |
| Socials |
About Arrakis Therapeutics
Arrakis has a simple but powerful vision: To extend small-molecule medicines into new realms of biology, unlocking that biology for medicine. Our approach builds on the existing sophisticated drug discovery toolkit developed for protein targets, which we are adapting and refocusing on discovering small-molecule compounds that act directly on RNA. We are pioneering new territory, with an expedition led by a team of skilled scientists and drug development leaders who are inventive yet pragmatic. We are on a bold and exciting mission, a mission not without peril, but we have an energized, collaborative, creative and fearless team – a team that has consistently breached barriers and blazed new trails in search of solutions. We are now poised to realize the promise of bringing RNA into play for small-molecule drug discovery. Pushing the frontier of this emerging field of science is gratifying, but our mission goes beyond the thrill of scientific discovery. We believe that by targeting RNA biology in new ways, we have the potential to impact millions of patients. Our platform will allow us to reach hundreds of biological targets not currently accessible to medicine, including known targets previously considered “undruggable.” Our destination is powerful new therapies for patients everywhere, by opening up a new path for discovering RNA-targeted medicines.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Arrakis Therapeutics has 20 employees across 8 departments.
Departments
Number of employees
Arrakis Therapeutics Tech Stack
Discover the technologies and tools that power Arrakis Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
Maps
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Miscellaneous
Programming languages
Blogs
Analytics
Development
Frequently asked questions
4.8
40,000 users



